Salvage therapy with sulbactam/durlobactam against cefiderocol-resistant Acinetobacter baumannii in a critically ill burn patient: clinical challenges and molecular characterization.
JAC Antimicrob Resist
; 5(3): dlad078, 2023 Jun.
Article
en En
| MEDLINE
| ID: mdl-37325251
Texto completo:
1
Base de datos:
MEDLINE
Idioma:
En
Revista:
JAC Antimicrob Resist
Año:
2023
Tipo del documento:
Article